172 related articles for article (PubMed ID: 36528660)
41. Patient-derived gene and protein expression signatures of NGLY1 deficiency.
Rauscher B; Mueller WF; Clauder-Münster S; Jakob P; Islam MS; Sun H; Ghidelli-Disse S; Boesche M; Bantscheff M; Pflaumer H; Collier P; Haase B; Chen S; Hoffman R; Wang G; Benes V; Drewes G; Snyder M; Steinmetz LM
J Biochem; 2022 Feb; 171(2):187-199. PubMed ID: 34878535
[TBL] [Abstract][Full Text] [Related]
42. N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1.
Yang K; Huang R; Fujihira H; Suzuki T; Yan N
J Exp Med; 2018 Oct; 215(10):2600-2616. PubMed ID: 30135079
[TBL] [Abstract][Full Text] [Related]
43. Multi-systemic involvement in NGLY1-related disorder caused by two novel mutations.
Heeley J; Shinawi M
Am J Med Genet A; 2015 Apr; 167A(4):816-20. PubMed ID: 25707956
[TBL] [Abstract][Full Text] [Related]
44. Ever-expanding NGLY1 biology.
Suzuki T; Yoshida Y
J Biochem; 2022 Feb; 171(2):141-143. PubMed ID: 34969094
[TBL] [Abstract][Full Text] [Related]
45. NGLY1 Deficiency: A Rare Newly Described Condition with a Typical Presentation.
Dabaj I; Sudrié-Arnaud B; Lecoquierre F; Raymond K; Ducatez F; Guerrot AM; Snanoudj S; Coutant S; Saugier-Veber P; Marret S; Nicolas G; Tebani A; Bekri S
Life (Basel); 2021 Feb; 11(3):. PubMed ID: 33673403
[TBL] [Abstract][Full Text] [Related]
46. Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-β-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease.
Bi Y; Might M; Vankayalapati H; Kuberan B
Bioorg Med Chem Lett; 2017 Jul; 27(13):2962-2966. PubMed ID: 28512024
[TBL] [Abstract][Full Text] [Related]
47. Development of a fluorescence and quencher-based FRET assay for detection of endogenous peptide:N-glycanase/NGLY1 activity.
Hirayama H; Tachida Y; Fujinawa R; Matsuda Y; Murase T; Nishiuchi Y; Suzuki T
J Biol Chem; 2024 Apr; 300(4):107121. PubMed ID: 38417795
[TBL] [Abstract][Full Text] [Related]
48. Liver-specific deletion of Ngly1 causes abnormal nuclear morphology and lipid metabolism under food stress.
Fujihira H; Masahara-Negishi Y; Akimoto Y; Hirayama H; Lee HC; Story BA; Mueller WF; Jakob P; Clauder-Münster S; Steinmetz LM; Radhakrishnan SK; Kawakami H; Kamada Y; Miyoshi E; Yokomizo T; Suzuki T
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165588. PubMed ID: 31733337
[TBL] [Abstract][Full Text] [Related]
49. An induced pluripotent stem cell line (NCATS-CL9075) from a patient carrying compound heterozygote mutations, p.R390P and p.L318P, in the NGLY1 gene.
Pradhan M; Farkhondeh A; Cheng YS; Xu M; Beers J; Zou J; Liu C; Might M; Rodems S; Baumgärtel K; Zheng W
Stem Cell Res; 2021 Jul; 54():102400. PubMed ID: 34051448
[TBL] [Abstract][Full Text] [Related]
50. Impaired catabolism of free oligosaccharides due to MAN2C1 variants causes a neurodevelopmental disorder.
Maia N; Potelle S; Yildirim H; Duvet S; Akula SK; Schulz C; Wiame E; Gheldof A; O'Kane K; Lai A; Sermon K; Proisy M; Loget P; Attié-Bitach T; Quelin C; Fortuna AM; Soares AR; de Brouwer APM; Van Schaftingen E; Nassogne MC; Walsh CA; Stouffs K; Jorge P; Jansen AC; Foulquier F
Am J Hum Genet; 2022 Feb; 109(2):345-360. PubMed ID: 35045343
[TBL] [Abstract][Full Text] [Related]
51. Mitochondrial function requires NGLY1.
Kong J; Peng M; Ostrovsky J; Kwon YJ; Oretsky O; McCormick EM; He M; Argon Y; Falk MJ
Mitochondrion; 2018 Jan; 38():6-16. PubMed ID: 28750948
[TBL] [Abstract][Full Text] [Related]
52. NGLY1 deficiency: Novel patient, review of the literature and diagnostic algorithm.
Lipiński P; Bogdańska A; Różdżyńska-Świątkowska A; Wierzbicka-Rucińska A; Tylki-Szymańska A
JIMD Rep; 2020 Jan; 51(1):82-88. PubMed ID: 32071843
[TBL] [Abstract][Full Text] [Related]
53. Loss of N-Glycanase 1 Alters Transcriptional and Translational Regulation in K562 Cell Lines.
Mueller WF; Jakob P; Sun H; Clauder-Münster S; Ghidelli-Disse S; Ordonez D; Boesche M; Bantscheff M; Collier P; Haase B; Benes V; Paulsen M; Sehr P; Lewis J; Drewes G; Steinmetz LM
G3 (Bethesda); 2020 May; 10(5):1585-1597. PubMed ID: 32265286
[TBL] [Abstract][Full Text] [Related]
54. Physiological importance of NGLY1, as revealed by rodent model analyses.
Fujihira H; Asahina M; Suzuki T
J Biochem; 2022 Feb; 171(2):161-167. PubMed ID: 34580715
[TBL] [Abstract][Full Text] [Related]
55. A method for assaying peptide: N-glycanase/N-glycanase 1 activities in crude extracts using an N-glycosylated cyclopeptide.
Hirayama H; Tachida Y; Seino J; Suzuki T
Glycobiology; 2022 Mar; 32(2):110-122. PubMed ID: 34939090
[TBL] [Abstract][Full Text] [Related]
56. NGLY1 mutations cause protein aggregation in human neurons.
Manole A; Wong T; Rhee A; Novak S; Chin SM; Tsimring K; Paucar A; Williams A; Newmeyer TF; Schafer ST; Rosh I; Kaushik S; Hoffman R; Chen S; Wang G; Snyder M; Cuervo AM; Andrade L; Manor U; Lee K; Jones JR; Stern S; Marchetto MC; Gage FH
Cell Rep; 2023 Dec; 42(12):113466. PubMed ID: 38039131
[TBL] [Abstract][Full Text] [Related]
57. New perspectives on the mutated NGLY1 enigma.
Tickotsky-Moskovitz N
Med Hypotheses; 2015 Nov; 85(5):584-5. PubMed ID: 26228302
[TBL] [Abstract][Full Text] [Related]
58. N-glycoproteomics reveals distinct glycosylation alterations in NGLY1-deficient patient-derived dermal fibroblasts.
Budhraja R; Saraswat M; De Graef D; Ranatunga W; Ramarajan MG; Mousa J; Kozicz T; Pandey A; Morava E
J Inherit Metab Dis; 2023 Jan; 46(1):76-91. PubMed ID: 36102038
[TBL] [Abstract][Full Text] [Related]
59. Transiently elevated plasma methionine,
Chang CA; Wei XC; Martin SR; Sinasac DS; Al-Hertani W
JIMD Rep; 2019 Sep; 49(1):21-29. PubMed ID: 31497478
[TBL] [Abstract][Full Text] [Related]
60. Lethality of mice bearing a knockout of the Ngly1-gene is partially rescued by the additional deletion of the Engase gene.
Fujihira H; Masahara-Negishi Y; Tamura M; Huang C; Harada Y; Wakana S; Takakura D; Kawasaki N; Taniguchi N; Kondoh G; Yamashita T; Funakoshi Y; Suzuki T
PLoS Genet; 2017 Apr; 13(4):e1006696. PubMed ID: 28426790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
